Brain-derived neurotrophic factor in neurodegenerative diseases

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Nature Reviews Neurology

• Publication date

  2009-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/nrneurol.2009.54PMID 19498435
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Age-at-onset in Huntington disease

  2011cited by this paper
• Analysis of the Repressor Element‐1 Silencing Transcription Factor/Neuron‐Restrictive Silencer Factor Occupancy of Non‐Neuronal Genes in Peripheral Lymphocytes from Patients with Huntington's Disease

  2010cited by this paper
• Effect of the brain‐derived neurotrophic factor and the apolipoprotein E polymorphisms on disease progression in preclinical Alzheimer’s disease

  2009cited by this paper
• Assessment of Alzheimer’s disease case–control associations using family-based methods

  2009cited by this paper
• A rosette-type, self-renewing human ES cell-derived neural stem cell with potential for in vitro instruction and synaptic integration

  2009cited by this paper
• Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease

  2009cited by this paper
• Emerging restorative treatments for Parkinson's disease.

  2008cited by this paper
• Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1.

  2008cited by this paper
• Huntingtin Regulates RE1-silencing Transcription Factor/Neuron-restrictive Silencer Factor (REST/NRSF) Nuclear Trafficking Indirectly through a Complex with REST/NRSF-interacting LIM Domain Protein (RILP) and Dynactin p150Glued*

  2008cited by this paper
• SNPs in Neurotrophin System Genes and Alzheimer's Disease in an Italian Population

  2008cited by this paper
• Long-term tripotent differentiation capacity of human neural stem (NS) cells in adherent culture.

  2008cited by this paper
• AAV–BDNF mediated attenuation of quinolinic acid-induced neuropathology and motor function impairment

  2008cited by this paper
• Brain‐derived neurotrophic factor over‐expression in the forebrain ameliorates Huntington’s disease phenotypes in mice

  2008cited by this paper
• Protective effect of BDNF against beta-amyloid induced neurotoxicity in vitro and in vivo in rats.

  2008cited by this paper
• Blood level of brain-derived neurotrophic factor mRNA is progressively reduced in rodent models of Huntington's disease: restoration by the neuroprotective compound CEP-1347.

  2008cited by this paper
• Phosphorylation of mutant huntingtin at S421 restores anterograde and retrograde transport in neurons.

  2008cited by this paper
• Sertraline slows disease progression and increases neurogenesis in N171-82Q mouse model of Huntington's disease.

  2008cited by this paper
• New insights into brain BDNF function in normal aging and Alzheimer disease.

  2008cited by this paper
• Enhanced Sensitivity of Striatal Neurons to Axonal Transport Defects Induced by Mutant Huntingtin

  2008cited by this paper
• Increase of BDNF serum concentration during donepezil treatment of patients with early Alzheimer’s disease

  2008cited by this paper
• Huntingtin phosphorylation acts as a molecular switch for anterograde/retrograde transport in neurons

  2008cited by this paper
• Nuclear receptor NR4A2 IVS6 +18insG and brain derived neurotrophic factor (BDNF) V66M polymorphisms and risk of Taiwanese parkinson's disease

  2007cited by this paper
• Induction of neostriatal neurogenesis slows disease progression in a transgenic murine model of Huntington disease.

  2007cited by this paper
• Expression Profiling of Huntington's Disease Models Suggests That Brain-Derived Neurotrophic Factor Depletion Plays a Major Role in Striatal Degeneration

  2007cited by this paper
• Dissecting the human BDNF locus: Bidirectional transcription, complex splicing, and multiple promoters

  2007cited by this paper
• RESEARCH ARTICLE: Systematic Assessment of BDNF and Its Receptor Levels in Human Cortices Affected by Huntington's Disease

  2007cited by this paper
• Small molecule neurotrophin receptor ligands: novel strategies for targeting Alzheimer's disease mechanisms.

  2007cited by this paper
• Widespread Disruption of Repressor Element-1 Silencing Transcription Factor/Neuron-Restrictive Silencer Factor Occupancy at Its Target Genes in Huntington's Disease

  2007cited by this paper
• BDNF tagging polymorphisms and haplotype analysis in sporadic Parkinson's disease in diverse ethnic groups.

  2007cited by this paper
• Role of brain-derived neurotrophic factor in Huntington's disease.

  2007cited by this paper
• Lack of association between the brain-derived neurotrophin factor (C-270T) polymorphism and late-onset Alzheimer’s disease (LOAD) in Brazilian patients

  2007cited by this paper
• BDNF serum and CSF concentrations in Alzheimer's disease, normal pressure hydrocephalus and healthy controls.

  2007cited by this paper
• Loss of Huntingtin Function Complemented by Small Molecules Acting as Repressor Element 1/Neuron Restrictive Silencer Element Silencer Modulators*

  2007cited by this paper
• Low brain‐derived neurotrophic factor (BDNF) levels in serum of Huntington's disease patients

  2007cited by this paper
• Cystamine and cysteamine increase brain levels of BDNF in Huntington disease via HSJ1b and transglutaminase.

  2006cited by this paper
• The expanding role of BDNF: a therapeutic target for Alzheimer's disease?

  2006cited by this paper
• No evidence of association between BDNF gene variants and age-at-onset of Huntington's disease.

  2006cited by this paper
• The Brain-Derived Neurotrophic Factor Val66Met Polymorphism and Rate of Decline in Alzheimer's disease

  2006cited by this paper
• The disease progression of Mecp2 mutant mice is affected by the level of BDNF expression.

  2006cited by this paper
• Shedding light into the role of BDNF in the pharmacotherapy of Parkinson's disease

  2006cited by this paper
• Reduced expression of the TrkB receptor in Huntington's disease mouse models and in human brain

  2006cited by this paper
• No association between polymorphisms in the BDNF gene and age at onset in Huntington disease

  2006cited by this paper
• Decreased brain-derived neurotrophic factor (BDNF)- and β-thromboglobulin (β-TG)- blood levels in Alzheimer’s disease

  2006cited by this paper
• Stage-dependent BDNF serum concentrations in Alzheimer’s disease

  2006cited by this paper
• Decreased brain-derived neurotrophic factor (BDNF)- and beta-thromboglobulin (beta-TG)- blood levels in Alzheimer's disease.

  2006cited by this paper
• Genetic variants in brain-derived neurotrophic factor associated with Alzheimer’s disease

  2006cited by this paper
• Variations in the BDNF Gene in Autopsy-Confirmed Alzheimer’s Disease and Dementia with Lewy Bodies in Japan

  2006cited by this paper
• Effective gene therapy with nonintegrating lentiviral vectors

  2006cited by this paper
• Genetic analysis of candidate genes modifying the age-at-onset in Huntington’s disease

  2006cited by this paper
• Molecular Trojan horses for blood-brain barrier drug delivery.

  2006cited by this paper
• No association between the brain-derived neurotrophic factor 196 G>A or 270 C>T polymorphisms and Alzheimer's or Parkinson's disease.

  2006cited by this paper
• Down regulation of trk but not p75NTR gene expression in single cholinergic basal forebrain neurons mark the progression of Alzheimer's disease

  2006cited by this paper
• Brain-derived neurotrophic factor does not influence age at neurologic onset of Huntington's disease.

  2006cited by this paper
• Human brain derived neurotrophic factor (BDNF) genes, splicing patterns, and assessments of associations with substance abuse and Parkinson's Disease

  2005cited by this paper
• A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease

  2005cited by this paper
• Inhibiting BDNF expression by antisense oligonucleotide infusion causes loss of nigral dopaminergic neurons.

  2005cited by this paper
• BDNF genetic variants are associated with onset age of familial Parkinson disease: GenePD Study

  2005cited by this paper
• Regional cortical thinning in preclinical Huntington disease and its relationship to cognition

  2005cited by this paper
• Progressive and selective striatal degeneration in primary neuronal cultures using lentiviral vector coding for a mutant huntingtin fragment.

  2005cited by this paper
• Precursor form of brain‐derived neurotrophic factor and mature brain‐derived neurotrophic factor are decreased in the pre‐clinical stages of Alzheimer's disease

  2005cited by this paper
• Brain-derived neurotrophic factor gene polymorphisms and Alzheimer’s disease

  2005cited by this paper
• Genetic variation in the brain derived neurotrophic factor gene in Alzheimer's disease

  2005cited by this paper
• Decreased levels of BDNF protein in Alzheimer temporal cortex are independent of BDNF polymorphisms.

  2005cited by this paper
• Investigation of the effect of brain-derived neurotrophic factor (BDNF) polymorphisms on the risk of late-onset Alzheimer's disease (AD) and quantitative measures of AD progression.

  2005cited by this paper
• Genetic analysis of BDNF and TrkB gene polymorphisms in Alzheimer’s disease

  2005cited by this paper
• Gene Therapy of Storage Disorders by Retroviral and Lentiviral Vectors

  2005cited by this paper
• Brain‐derived neurotrophic factor gene polymorphisms in Japanese patients with sporadic Alzheimer's disease, Parkinson's disease, and multiple system atrophy

  2005cited by this paper
• Risk of late-onset Alzheimer's disease associated with BDNF C270T polymorphism.

  2005cited by this paper
• BDNF is induced by wild-type α-synuclein but not by the two mutants, A30P or A53T, in glioma cell line

  2005cited by this paper
• Nature, nurture and neurology: gene–environment interactions in neurodegenerative disease

  2005cited by this paper
• Brain-Derived Neurotrophic Factor Is Required for the Establishment of the Proper Number of Dopaminergic Neurons in the Substantia Nigra Pars Compacta

  2005cited by this paper
• Brain-Derived Neurotrophic Factor Regulates the Onset and Severity of Motor Dysfunction Associated with Enkephalinergic Neuronal Degeneration in Huntington's Disease

  2004cited by this paper
• Brain-derived neurotrophic factor.

  2004cited by this paper
• Induction of Brain-Derived Neurotrophic Factor in Plaque-Associated Glial Cells of Aged APP23 Transgenic Mice

  2004cited by this paper
• Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules.

  2004cited by this paper
• Early Striatal Dendrite Deficits followed by Neuron Loss with Advanced Age in the Absence of Anterograde Cortical Brain-Derived Neurotrophic Factor

  2004cited by this paper
• Caloric restriction increases neurotrophic factor levels and attenuates neurochemical and behavioral deficits in a primate model of Parkinson's disease

  2004cited by this paper
• Association of a variation in the promoter region of the brain-derived neurotrophic factor gene with familial Parkinson's disease.

  2004cited by this paper
• Association Analysis of Brain-Derived Neurotrophic Factor Val66Met Polymorphisms with Alzheimer’s Disease and Age of Onset

  2004cited by this paper
• BDNF is induced by wild-type alpha-synuclein but not by the two mutants, A30P or A53T, in glioma cell line.

  2004cited by this paper
• Deep brain stimulation for Parkinson's disease: Potential risk of tissue damage associated with external stimulation

  2004cited by this paper
• Brain-derived neurotrophic factor (BDNF) Val66Met polymorphisms in Parkinson's disease and age of onset.

  2003cited by this paper
• BDNF gene expression is reduced in the frontal cortex of dopamine transporter knockout mice

  2003cited by this paper
• Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes

  2003cited by this paper
• Toward identification of susceptibility genes for sporadic Parkinson’s disease

  2003cited by this paper
• Direct brain infusion of glial cell line–derived neurotrophic factor in Parkinson disease

  2003cited by this paper
• A polymorphism of the brain-derived neurotrophic factor (BDNF) is associated with Alzheimer's disease in patients lacking the Apolipoprotein E ε4 allele

  2002cited by this paper
• Animal model of dementia induced by entorhinal synaptic damage and partial restoration of cognitive deficits by BDNF and carnitine

  2002cited by this paper
• Association studies of multiple candidate genes for Parkinson's disease using single nucleotide polymorphisms

  2002cited by this paper
• Neural stem cell therapy for neurological diseases: dreams and reality

  2002cited by this paper
• Modification of brain aging and neurodegenerative disorders by genes, diet, and behavior.

  2002cited by this paper
• Loss of Huntingtin-Mediated BDNF Gene Transcription in Huntington's Disease

  2001cited by this paper
• Alzheimer's disease results from the cerebral accumulation and cytotoxicity of amyloid ß-protein

  2001cited by this paper
• A novel polymorphism of the brain-derived neurotrophic factor (BDNF) gene associated with late-onset Alzheimer's disease

  2001cited by this paper
• Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's disease.

  2001cited by this paper
• BDNF and epilepsy: too much of a good thing?

  2001cited by this paper
• Brain-derived neurotrophic factor in Huntington disease.

  2000cited by this paper
• A phase I/II trial of recombinant methionyl human brain derived neurotrophic factor administered by intrathecal infusion to patients with amyotrophic lateral sclerosis

  2000cited by this paper
• Neurotrophins: key regulators of cell fate and cell shape in the vertebrate nervous system.

  2000cited by this paper
• A controlled trial of recombinant methionyl human BDNF in ALS

  1999cited by this paper

• Polyphenol-Loaded Plant Extracellular Vesicles: A New Approach to Combat AGEs-Induced Neurotoxicity via the Microbiota-Gut-Brain Axis.

  2026cites this paper
• Molecular evidence associating GLP-1 receptor agonists and brain-derived neurotrophic factors in neurodegenerative and psychiatric disorders: A systematic review.

  2026cites this paper
• Disruption of BDNF signalling in neuropathologies.

  2026cites this paper
• Making of BDNF: role of promoters, enhancers, and untranslated regions.

  2026cites this paper
• Swertisin improves Alzheimer's disease-like pathology in 5XFAD male mice through regulation in plasmin activity.

  2026cites this paper
• From trauma to depression: structural, synaptic, epigenetic, and molecular pathways linking early stress to lifelong vulnerability

  2025cites this paper
• The Reconstruction of Peripheral Auditory Circuit: Recent Advances and Future Challenges

  2025cites this paper
• Low-Intensity Ultrasound and Neural Repair: Unlocking Brain Plasticity and Functional Recovery.

  2025cites this paper
• Age-related memory decline is accelerated by pinealectomy in young adult and middle-aged rats via BDNF / ERK / CREB signalling.

  2025cites this paper
• Crossing Barriers: Advancements in Macromolecular Therapeutics for Neurodegenerative Diseases and Strategies to Overcome the Blood-Brain Barrier.

  2025cites this paper
• Exercise-induced neurogenesis through BDNF-TrkB pathway: implications for neurodegenerative disorders

  2025cites this paper
• In vitro generation of spiral ganglion neurons from embryonic stem cells

  2025cites this paper
• Interplay between Exercise and Neuregulin in providing neuroprotection.

  2025cites this paper
• Tailored brain metastatic tumor cells-derived apoptotic bodies ameliorate Alzheimer’s disease by promoting microglia efferocytosis and neuroinflammation mitigation

  2025cites this paper
• Adipose chemokine ligand CX3CL1 contributes to maintaining the hippocampal BDNF level, and the effect is attenuated in advanced age

  2025cites this paper
• Therapeutic Yoga Enhances Neuroplasticity and Metabolic Regulation Through Elevated Plasma Brain-Derived Neurotrophic Factor (BDNF) and Ghrelin in a Heterogeneous Cancer Survivor Population

  2025cites this paper
• Inhibition of PTPRS function does not affect the survival or regeneration of dopaminergic neurons but alters synaptic function in the nigrostriatal pathway

  2025cites this paper
• Long-term functional rescue of trauma-induced vision loss by a novel, small molecule TrkB modulator

  2025cites this paper
• A critical review on neurodegenerative biomarker diagnostics: where is the field heading to?

  2025cites this paper
• Application of Neurotrophic Factors as a Therapeutic Approach for Neurodegenerative Diseases

  2025cites this paper
• Role of growth factors and their interplay during oligodendroglial differentiation and maturation.

  2025cites this paper
• Amelioration of Astrocytic Dysfunction via AQP4/LRP1 Pathway by Zizania latifolia and Tricin in C6 Cells Exposed to Amyloid β and High-Dose Insulin and in Mice Treated with Scopolamine

  2025cites this paper
• Pridopidine, a Potent and Selective Therapeutic Sigma-1 Receptor (S1R) Agonist for Treating Neurodegenerative Diseases

  2025influential citation
• Low-speed uphill exercise increases lactate and brain-derived neurotrophic factor in brain regions for memory and learning.

  2025cites this paper
• Serum zonulin, brain-derived neurotrophic factor, and oxidative stress levels in individuals using paper (A4) impregnated with synthetic cannabinoids

  2025cites this paper
• The association of brain-derived neurotrophic factor Val66Met polymorphism with stroke outcomes: a cross-sectional pilot study

  2025cites this paper
• Evaluation of proliferative activity of the dipeptide mimetics of the 1st, 2nd and 4th loops of the brain-derived neurotrophic factor in vitro

  2025cites this paper
• AMPA receptor diffusional trapping machinery as an early therapeutic target in neurodegenerative and neuropsychiatric disorders

  2025cites this paper
• Safety and efficacy of transcranial ultrasound stimulation for the treatment of Alzheimer's disease: A randomized, double-blind, placebo-controlled trial.

  2025cites this paper
• Exercise-Induced Changes in Brain-Derived Neurotrophic Factor in Neurodegenerative Diseases: A Bayesian Network Meta-Analysis.

  2025cites this paper
• Can ketamine therapy overcome treatment-resistant depression in Alzheimer's disease and older adults? Preclinical and clinical evidence.

  2025cites this paper
• Long-Term Functional Rescue of Trauma-Induced Vision Loss by a Novel, Small Molecule TrkB Activator

  2025cites this paper
• Repurposing major metabolites of lamiaceae family as potential inhibitors of α-synuclein aggregation to alleviate neurodegenerative diseases: an in silico approach

  2025cites this paper
• 基于离体神经网络的生物智能计算：关键技术与研究现状(特邀)

  2025cites this paper
• Dementia with Lewy Bodies (DLB), Parkinson’s Disease (PD), and Multiple System Atrophy (MSA) Are Synucleopathies Characterized by Increased Serum Levels of Plasminogen Activator Inhibitor‑1 (PAI-1)

  2025cites this paper
• HIITing Anxiety and Depression in Parkinson’s Disease and Multiple Sclerosis—A Study Protocol of a Transdiagnostic Randomized Controlled Trial (HersenFIT)

  2025influential citation
• Neurovascular unit, neuroinflammation and neurodegeneration markers in brain disorders

  2024cites this paper
• Exercise, Neuroprotective Exerkines, and Parkinson’s Disease: A Narrative Review

  2024cites this paper
• Serum Mature and Precursor Brain-Derived Neurotrophic Factors and Their Association with Neurocognitive Function in ART-Naïve Adults Living with HIV in Sub-Saharan Africa

  2024cites this paper
• A review on gut microbiota and miRNA crosstalk: implications for Alzheimer’s disease

  2024cites this paper
• Pattern of cognitive changes and content of cerebral neurotrophic factor in patients with chronic cerebral ischemia

  2024cites this paper
• Brain-derived neurotrophic factor plays with TRiC: focus on synaptic dysfunction in Huntington’s disease

  2024cites this paper
• A highly bioavailable curcumin formulation ameliorates inflammation cytokines and neurotrophic factors in mice with traumatic brain injury

  2024cites this paper
• Beneficial effects of physical exercise on cognitive-behavioral impairments and brain-derived neurotrophic factor alteration in the limbic system induced by neurodegeneration.

  2024cites this paper
• Serum brain-derived neurotrophic factor level in patients with disc induced lumbosacral radiculopathy: Relation to pain severity and functional disability.

  2024cites this paper
• Seasonal fluctuations in BDNF regulate hibernation and torpor in golden-mantled ground squirrels.

  2024cites this paper
• New opportunities for antioxidants in amelioration of neurodegenerative diseases.

  2024cites this paper
• BDNF-loaded chitosan-based mimetic mussel polymer conduits for repair of peripheral nerve injury

  2024cites this paper
• Valproic acid and/or rapamycin preconditioning protects hair follicle stem cells from oxygen glucose serum deprivation-induced oxidative injury via activating Nrf2 pathway

  2024cites this paper
• Efficacy of Antidepressants in Management of Depressive Symptoms in Dementia: A Systematic Review and Meta-analysis of Randomized Controlled Trials

  2024cites this paper
• Time to Dementia Diagnosis Among Veterans with Comorbid Insomnia and Depressive Episodes

  2024cites this paper
• The impact of BDNF and CD4 + T cell crosstalk on depression

  2024cites this paper
• Associations of Multimorbidity with Cerebrospinal Fluid Biomarkers for Neurodegenerative Disorders in Early Parkinson's Disease: A Cross-sectional and Longitudinal Study.

  2024cites this paper
• Ghrelin/GHSR System in Depressive Disorder: Pathologic Roles and Therapeutic Implications

  2024cites this paper
• Repeated exposure to novelty promotes resilience against the amyloid-beta effect through dopaminergic stimulation

  2024cites this paper
• The interplay between BDNF and PGC-1 alpha in maintaining brain health: role of exercise

  2024cites this paper
• Therapeutic Importance of Exercise in Neuroplasticity in Adults with Neurological Pathology: Systematic Review

  2024cites this paper
• Effects and mechanisms of harmine on ameliorating ethanol-induced memory impairment.

  2024cites this paper
• Saroglitazar, a PPAR α/γ agonist alleviates 3-Nitropropionic acid induced neurotoxicity in rats: Unveiling the underlying mechanisms.

  2024cites this paper
• Physical Exercise and Mechanism Related to Alzheimer’s Disease: Is Gut–Brain Axis Involved?

  2024cites this paper
• Rhoifolin, baicalein 5,6-dimethyl ether and agathisflavone prevent amnesia induced in scopolamine zebrafish (Danio rerio) model by increasing the mRNA expression of bdnf, npy, egr-1, nfr2α, and creb1 genes.

  2024cites this paper
• Vindeburnol: A natural product-inspired chemical tool for central nervous system drug design.

  2024cites this paper
• Air pollution, cardiorespiratory fitness and biomarkers of oxidative status and inflammation in the 4HAIE study

  2024cites this paper
• Brain-derived neuerotrophic factor and related mechanisms that mediate and influence progesterone-induced neuroprotection

  2024cites this paper
• From Gut to Brain: Uncovering Potential Serum Biomarkers Connecting Inflammatory Bowel Diseases to Neurodegenerative Diseases

  2024cites this paper
• BDNF and TRiC-inspired reagent rescue cortical synaptic deficits in a mouse model of Huntington’s disease

  2024cites this paper
• Food-Derived Peptides as Promising Neuroprotective Agents: Mechanism and Therapeutic Potential.

  2024cites this paper
• Altered mitochondrial Ca2+ uptake in presynaptic terminals of cultured striatal and cortical neurons from the zQ175 knock-in mouse model of Huntington's disease.

  2024cites this paper
• Adjunctive treatments for pneumococcal meningitis: a systematic review of experimental animal models

  2024cites this paper
• The protective effects of repetitive transcranial magnetic stimulation with different high frequencies on motor functions in MPTP/probenecid induced Parkinsonism mouse models

  2024cites this paper
• Recent advances in the crosstalk between the brain-derived neurotrophic factor and glucocorticoids

  2024cites this paper
• Perinatal Tissue-Derived Stem Cells: An Emerging Therapeutic Strategy for Challenging Neurodegenerative Diseases

  2024cites this paper
• Exercise mimetics: a novel strategy to combat neuroinflammation and Alzheimer’s disease

  2024cites this paper
• Exploring environmental exposomes and the gut-brain nexus: Unveiling the impact of pesticide exposure.

  2024cites this paper
• Enhanced peripheral levels of BDNF and proBDNF: elucidating neurotrophin dynamics in cocaine use disorder

  2024cites this paper
• GADD45B in the ventral hippocampal CA1 modulates aversive memory acquisition and spatial cognition.

  2024cites this paper
• Presumptive Molecular Interconnections Between COVID-19 And Huntington’s Disease

  2024cites this paper
• Navigating the Labyrinth: Understanding Dementia’s Effect on the Brain and the Role of Educational Therapy-Based Interventions in Dementia Treatment

  2024cites this paper
• Protein and peptide from blue food for neurological disorder: Advances and prospective

  2024cites this paper
• Neuroimaging techniques, gene therapy, and gut microbiota: frontier advances and integrated applications in Alzheimer’s Disease research

  2024cites this paper
• PRG ameliorates cognitive impairment in Alzheimer's disease mice by regulating β-amyloid and targeting the ERK pathway.

  2024cites this paper
• Pathological Impact of Redox Post-Translational Modifications

  2024cites this paper
• Content CN-21-5

  2023cites this paper
• The probable role of tissue plasminogen activator/neuroserpin axis in Alzheimer’s disease: a new perspective

  2023cites this paper
• Role of Neuronal TRPC6 Channels in Synapse Development, Memory Formation and Animal Behavior

  2023cites this paper
• Ni and Al mixture amplifies cerebellar oxido-inflammatory responses, down regulates AChE and BDNF/NGF levels in motor impairment in male albino rats.

  2023cites this paper
• Unique Transcriptional Signatures Observed in Stem Cells from the Dental Pulp of Deciduous Teeth Produced on a Large Scale

  2023cites this paper
• Physical exercise and its effects on people with Parkinson’s disease: Umbrella review

  2023cites this paper
• Association of polymorphic variants of the gene BDNF in human adaptation to extreme environmental conditions and life expectancy

  2023cites this paper
• Altered anterograde axonal transport of mitochondria in cultured striatal neurons of a knock-in mouse model of Huntington's disease.

  2023cites this paper
• Serum PAI-1/BDNF Ratio Is Increased in Alzheimer’s Disease and Correlates with Disease Severity

  2023cites this paper
• Neuron‐derived extracellular vesicles contain synaptic proteins, promote spine formation, activate TrkB‐mediated signalling and preserve neuronal complexity

  2023cites this paper
• The role of neurotrophic factors in novel, rapid psychiatric treatments

  2023cites this paper
• Triangulating evidence from observational and Mendelian randomization studies of ketone bodies for cognitive performance

  2023cites this paper
• Exploring the Preliminary Effects of Resistance Training on Total Brain-Derived Neurotrophic Factor (BDNF) Levels in Elderly Individuals: A Pilot Study

  2023cites this paper
• Ginsenoside Rg1 attenuates D‐galactose‐induced neural stem cell senescence via the Sirt1‐Nrf2‐BDNF pathway

  2023cites this paper
• Activin A targets extrasynaptic NMDA receptors to improve neuronal and behavioral deficits in a mouse model of Huntington disease

  2023cites this paper
• Beyond Motor Deficits: Environmental Enrichment Mitigates Huntington’s Disease Effects in YAC128 Mice

  2023cites this paper
• Brain-derived neurotrophic factor: Its role in energy balance and cancer cachexia.

  2023cites this paper
• COMT Val158Met and BDNF Val66Met Single-Nucleotide Polymorphisms Are Not Associated With Emotional Distress One Year After Moderate-Severe Traumatic Brain Injury

  2023cites this paper